NCT06146751View on ClinicalTrials.gov

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Heart Aneurysm
Interventions
DRUG

Superparamagnetic Iron Oxide Nanoparticles

Patients will receive a novel ferumoxytol-enhanced cardiac magnetic resonance imaging.

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER